Abstract:Objective: The study aimed to employ the pharmacophore hybridization technique for the synthesis of novel anticancer compounds by combining the pyrazole moiety with 1,2,4-triazole and 1,3,4-oxadizaole moieties. Methods: Two series of compounds were synthesized, purified, and structurally characterized. The compounds were tested for HDAC inhibitory properties on HDAC4 and HDAC8 isoforms, with a focus on HDAC8 selectivity. Results: Among the synthesized derivatives, an intriguing HDAC8 selectivity was observed. Fourteen compounds were further evaluated for preliminary cytotoxicity across nine solid tumor cell lines. Compound ( IXt ) demonstrated notable activity against three cell lines. Detailed analysis revealed that caspase activation played a significant role in the cytotoxic effects of ( IXt ). Cell cycle analysis indicated disruption with decreased cell populations in S and G2/M phases. Discussion: The study underscores the potential of hybridizing diaryl pyrazolines with oxadiazole and triazole 5-membered heterocycles. The observed HDAC8 selectivity and significant cytotoxic effects, particularly with compound ( IXt ), suggest promising avenues for the development of novel anticancer leads. Conclusions: The hybridization strategy employed in this study, combining diaryl pyrazolines with specific heterocycles, presents a viable approach for the synthesis of anticancer compounds. The identified HDAC8 selectivity and cytotoxicity against multiple cell lines, especially with compound ( IXt ), warrant further exploration and development of these derivatives as potential anticancer agents.

Pyrazolo [3,4-D]pyrimidine-based Dual HDAC/Topo II Inhibitors: Design, Synthesis, and Biological Evaluation As Potential Antitumor Agents

Design, synthesis and biological evaluation of dual Topo II/HDAC inhibitors bearing pyrimido[5,4-b]indole and pyrazolo[3,4-d]pyrimidine motifs.

Synthesis and Biological Evaluation of Novel Pyrazoline Derivatives Containing Indole Skeleton As Anti-Cancer Agents Targeting Topoisomerase II.

Design, Synthesis and Anticancer Evaluation of Acridine Hydroxamic Acid Derivatives As Dual Topo and HDAC Inhibitors.

Design, Synthesis and Biological Evaluation of Novel (Quinolinyl-3-pyridinyl)benzenesulfonamide-based Hydroxamic Acids As PI3K and HDAC Dual Targeting Inhibitors

Design, Synthesis and Biological Activity of Pyrazolo[3,4-d]pyrimidine Derivatives Containing Indole Moiety

Synthesis and Mechanism Studies of 1,3-Benzoazolyl Substituted Pyrrolo[2,3-b]pyrazine Derivatives As Nonintercalative Topoisomerase II Catalytic Inhibitors.

Synthesis of novel pyrazole derivatives as promising DNA-binding agents and evaluation of antitumor and antitopoisomerase I/II activities.

Design, facile synthesis and biological evaluations of novel pyrano[3,2-a]phenazine hybrid molecules as antitumor agents.

The Discovery and Optimization of Novel Dual Inhibitors of Topoisomerase Ii and Histone Deacetylase

Diaryl Pyrazoline, 1,3,4-Oxadizole, and 1,2,4-Triazole Pharmacophore Hybridization: Design, Synthesis, HDAC Inhibition, and Caspase 3/7 Activation Studies

Synthesis, biological evaluation, and molecular docking studies of pyrazolyl-acylhydrazone derivatives as novel anticancer agents

Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II.

Synthesis and Anticancer Research ofN-(2-aminophenyl)benzamide Acridine Derivatives as Dual Topoisomerase I and Isoform-Selective HDAC Inhibitors

Synthesis and investigation of novel 6-(1,2,3-triazol-4-yl)-4-aminoquinazolin derivatives possessing hydroxamic acid moiety for cancer therapy.

Design and Synthesis of 2-Phenylnaphthalenoids and 2-Phenylbenzofuranoids As DNA Topoisomerase Inhibitors and Antitumor Agents

Synthesis, biological evaluation, and in silico studies of indole‐tethered pyrazoline derivatives as anticancer agents targeting topoisomerase IIα

Design and synthesis of triazolopyridine derivatives as potent JAK/HDAC dual inhibitors with broad-spectrum antiproliferative activity

Design, synthesis and biological evaluation of novel phthalazinone acridine derivatives as dual PARP and Topo inhibitors for potential anticancer agents

Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents.

Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.